Vincenzo Cimino

Milan, 20157, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.

The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 26, 2025

Psychotropic effects of GLP-1R agonists.

Psychotropic effects of GLP-1R agonists.

Journal: Pharmacological research

Published: September 15, 2025

A Randomized Study of the Glunovo Real-time CGM Effectiveness in Individuals With Poorly Controlled Type 2 Diabetes.

A Randomized Study of the Glunovo Real-time CGM Effectiveness in Individuals With Poorly Controlled Type 2 Diabetes.

Journal: Journal of the Endocrine Society

Published: August 09, 2025

The role of the incretin GIP in inflammation.

The role of the incretin GIP in inflammation.

Journal: Journal of endocrinological investigation

Published: August 02, 2025

Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE- 2 study.

Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE- 2 study.

Journal: Pharmacological research

Published: January 30, 2025

Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study.

Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study.

Journal: Pharmacological research

Published: October 22, 2024

A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus.

A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus.

Journal: Journal of diabetes and metabolic disorders

Published: July 03, 2024

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide.

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide.

Journal: Pharmacological research

Published: November 09, 2023

Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers.

Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers.

Journal: International journal of molecular sciences

Published: September 05, 2022

Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study.

Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study.

Journal: Pharmacological research

Published: June 19, 2022

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.

Journal: Pharmacological research

Published: June 13, 2022

Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.

Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.

Journal: Frontiers in endocrinology

Published: November 16, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026